A Single Center, Observational Study to Evaluate the Effectiveness and Safety of Cryotherapy in Combination with 10% ALA Gel Red Light PDT in the Treatment of Actinic Keratosis on the Full Face.

Status: Recruiting
Location: See location...
Intervention Type: Drug, Procedure, Device
Study Type: Interventional
Study Phase: Phase 4
SUMMARY

40 patients randomized 1:1 to receive cryotherapy followed by 10% ALA gel Red light PDT vs. to 10% ALA gel Red Light PDT followed by cryotherapy.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Male or female adult ≥ 18 years of age;

• 6-12 actinic keratosis grade I, II, and III on the full face.

• Willing to avoid excessive sunlight or ultraviolet (UV) light exposure, including the use of tanning beds, to the face or scalp during study participation.

• Females of childbearing potential (FCBP) must have a negative serum pregnancy test at Screening and negative urine pregnancy test at Baseline. FCBP who engage in activity in which conception is possible must use one of the approved contraceptive options: hormonal contraception; intrauterine device (IUD); tubal ligation; or partner's vasectomy; Male or female condom diaphragm with spermicide, cervical cap with spermicide, or contraceptive sponge with spermicide.

• Able and willing to give written informed consent prior to performance of any study-related procedures

Locations
United States
New Jersey
Psoriasis Treatment Center of New Jersey
RECRUITING
East Windsor
Contact Information
Primary
Ashley Reed
ashley.reed@schweigerderm.com
609-443-4500
Time Frame
Start Date: 2023-05-03
Estimated Completion Date: 2025-06
Participants
Target number of participants: 40
Treatments
Experimental: cryotherapy followed by 10% ALA gel Red light PDT
Experimental: 10% ALA gel Red Light PDT followed by cryotherapy
Related Therapeutic Areas
Sponsors
Leads: Psoriasis Treatment Center of Central New Jersey
Collaborators: Biofrontera Bioscience GmbH

This content was sourced from clinicaltrials.gov